Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,668 INR | -0.08% | +0.04% | -0.81% |
Strengths
- The company returns high margins, thereby supporting business profitability.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 35.69 and 26.86 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 4.55 times the sales for the current fiscal year, the company turns out to be overvalued.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.81% | 1.27B | C+ | ||
-5.94% | 266B | A- | ||
-3.51% | 93.75B | C+ | ||
-1.70% | 44.14B | C+ | ||
+6.16% | 40.42B | B- | ||
-1.60% | 39.92B | B- | ||
+7.31% | 39.47B | B- | ||
-18.07% | 29.26B | B- | ||
-7.67% | 28.39B | A | ||
+12.84% | 25.04B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ZYDUSWELL Stock
- Ratings Zydus Wellness Limited